BlueOcean NutraSciences Inc.

BlueOcean NutraSciences Inc.

November 24, 2015 11:57 ET

BlueOcean NutraSciences Announces First Purchase Orders from Amazon for Pure Polar Omega-3 Shrimp Oil Products

TORONTO, ONTARIO--(Marketwired - Nov. 24, 2015) - BlueOcean NutraSciences (TSX VENTURE:BOC) ("BlueOcean" or the "Company") is a nutraceutical Company focused on developing specialty oils and Extended Release (XR) Omega-3 tablets from shrimp, fish, krill and algae oil for Health and Wellness markets. BOC is pleased to announce that its subsidiary, Pure Polar Labs Inc., has received its first wholesale purchase orders for Pure Polar Regular Strength and Double Strength Omega-3 Shrimp Oil products from Amazon, the World's largest e-retailer. Regular Strength is available now at while Double Strength should be available on-line at Amazon next week.

Amazon is now also the largest e-retailer of dietary supplements according to a report by Wells Fargo. Of surveyed supplements purchasers, 7% said they bought supplements directly from Amazon. A report published by GOED (Global Organization for EPA and DHA) in May 2015 showed the top Omega-3 brands on Amazon generate an average of $1.5 million in annual sales from nearly 35,000 bottles sold through Amazon alone.

Pure Polar™ Omega-3 Shrimp Oil formulations are competing in the Omega-3 supplements category online at Pure Polar™'s key product advantages over Omega-3 krill oil competitors are that they contain over two times more Omega-3 EPA & DHA and 10 times more astaxanthin than typical retail Omega-3 krill oil brands, and contain phospholipids like krill for better absorption of Omega-3s versus Omega-3 fish oil brands. By being price competitive with krill, Pure Polar™ offers consumers more value with a more complete Omega-3 supplement for the maintenance of good health.

In Q1 2016, Pure Polar Labs Inc. intends to launch a Triple Strength and Super Strength Pure Polar Omega-3 Shrimp Oil gel cap, and a Pure Polar Extended Release Omega-3 Fish Oil tablet. Pure Polar Labs also intends to launch a line of shrimp oils targeted at the high value and rapidly growing natural astaxanthin supplement market. These shrimp oils will contain high levels of natural astaxanthin including phospholipids and Omega-3s, and will be branded as an "Astaxanthin Shrimp Oil" product line.

About BlueOcean NutraSciences:

BlueOcean NutraSciences Inc. is a Canadian listed public Company (TSX VENTURE:BOC) that is focused on developing sustainable, specialty nutraceutical oil products targeted at the rapidly growing Natural Astaxanthin, Omega-3 and Algal oil health and wellness markets. BlueOcean's bulk shrimp oils contain high levels of naturally occurring astaxanthin, phospholipids, and Omega-3 EPA and DHA. Northern and Pacific AstaShrimp™ bulk oils are targeted at the high value and rapidly growing natural astaxanthin and phospholipid Omega-3 markets.

BlueOcean and its JV partner, CMAX technologies, have developed a process to convert shrimp, krill, algae and other fish oils into Extended Release Tablets. BlueOcean owns 50% of the participating and voting rights in 2453969 Ontario Inc., a joint venture with CMAX Technologies that has developed the extended release Omega-3/astaxanthintablets. 2453969 Ontario Inc. also has a 66.7% ownership in Pure Polar Labs Inc., a Nevada company that sells Omega-3 and astaxanthin retail products under the brand Pure Polar.

BlueOcean's Pure Polar™ Omega-3 Shrimp Oil formulations contain over two times more Omega-3 EPA & DHA and 10 times more astaxanthin than typical retail krill oil brands, and contain phospholipids for better absorption of Omega-3s. Product details and ordering can be found at: and a number of online retail stores including

Forward Looking Statements: BlueOcean

This news release may contain forward-looking statements that are based on BlueOcean's expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • BlueOcean NutraSciences Inc.
    Gavin Bogle

    BlueOcean NutraSciences Inc.
    Director of Corporate Development